期刊文献+

生长抑素受体亚型在人肝星状细胞的表达及其临床意义 被引量:6

Expressions of Subtypes of Somatostatin Receptors in Activated Human Hepatic Stellate Cells and Its Clinical Significance
下载PDF
导出
摘要 目的研究人肝星状细胞系(LX-2细胞)生长抑素受体(somatostatin receptor,SSTR)亚型的表达情况,探讨其临床意义。方法选择对数生长期的LX-2细胞,将细胞以8×10^6个/孔接种于预置入盖玻片的6孔板中,分为LX-2组、中药复方861组、奥曲肽(octreotide)处理组及SSTR亚型阳性细胞(PANC-1)对照组,每组重复2孔。应用免疫细胞化学染色方法,观察LX-2细胞SSTR2、SSTR5的表达;用RT-PCR方法观察SSTR亚型1~5的表达。结果免疫细胞化学染色结果发现,LX-2细胞SSTR亚型2、5表达阳性,阳性物质呈棕红色,主要位于细胞膜及细胞质,复方861处理组SSTR2、5表达增强,细胞着色较深;RT—PCR结果发现,LX-2细胞SSTR亚型1~5的表达均阳性,阳性表达的高低依次为SSTR1、SSTR4〉SSTR2、SSTR5〉SSTR3(P〈0.05)。结论LX-2表达5种SSTR亚型,肝星状细胞可能是SST及其类似物降低门静脉压力的作用靶点。奥曲肽可能通过SSTR2、SSTR5亚型调节肝星状细胞的舒张与收缩功能,从而影响肝内阻力及门静脉压力。 Objective To study the expressions of somatostatin receptor subtypes in human activated hepatic stellate cells (LX-2). Its clinical significances was also surveyed. Methods To detect the expressions of SSTR2/5 of LX-2 which is in the logarithmic growth cycle using immunocytochemistry staining method: LX-2 were routinely cultured on small glass coverslip in six well cluster dishes at a density of 8 × 10g cells/well. The cells were divided into 5 subgroups: compound 861 0.5 g/L,compound 861 1.0 g/L,octreotide 1 mg/L and control group,PNAC-1 was a positive control cell line. Meantime,expressions of SSTR1 -5 mRNA were observed using RT-PCR method. Results The expressions of SSTR 2, SSTR5 in LX-2 were positive after immunocyto-chemistry staining. The mainly staining site is cellular membrane and cellular plasm. The strong expressions in compound 861-treated group were also observed. The five kinds of subtypes of SSTR in LX-2 were proven to be positive via the detection of RT-PCR. To compared the level of the subtypes, SSTR1,4〉SSTR2,5〉SSTR3 was observed. Conclusion LX-2 expresses five kinds of somatostatin receptors subtype. It is suggested that the activated hepatic stellate cells is target of SST and its analogs.
出处 《首都医科大学学报》 CAS 2006年第4期441-444,共4页 Journal of Capital Medical University
基金 北京市科技新星计划(954812500)资助项目
关键词 肝星状细胞 生长抑素受体亚型 复方861 奥曲肽 hepatic stellate cell somatostatin receptor subtype compound 861 octreotide
  • 相关文献

参考文献9

  • 1Xu L,Hui A Y,Albanis E,et al.Human hepatic stellate cell lines,LX-1 and LX-2:new tools for analysis of hepatic fibrosis[J].Gut,2005,54:142-151.
  • 2Reynaert H,Geerts A.Pharmacological rationale for the use of somatostatin and analogues in portal hypertension[J].Aliment Pharmacol Ther,2003,18:375-386.
  • 3丁惠国,尚宏伟,王兴翠,唐素珍,孙异临,贾继东,赵春惠,王宝恩.复方861对活化肝星状细胞超微结构及细胞骨架蛋白的影响[J].中华肝脏病杂志,2005,13(7):553-554. 被引量:3
  • 4黄春,丁惠国,徐燕琳,唐淑珍,王宝恩,贾继东,赵春惠.奥曲肽对肝星状细胞钙离子浓度的影响及其意义[J].中华消化杂志,2002,22(8):508-509. 被引量:2
  • 5Gisbert Weckbecker,Ian Lewis,Rainer Albert,et al.Opportunities in somatostatin research:biological,chemical and therapeutic aspects[J].Nature,2003,12,2:999-1017.
  • 6Reynaert H,Rombouts K,Vandermonde A,et al.Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma[J].Gut,2004,53:1180-1189.
  • 7潘勤,陆良勇,李定国,尤汉宁,徐芹芳.生长抑素受体与肝星状细胞活化的相关性研究[J].中华消化杂志,2004,24(6):374-376. 被引量:7
  • 8宋盛晗,冷希圣,李涛,彭吉润,秦致中,赵力,魏玉华,于鑫.大鼠肝星状细胞中生长抑素受体表达的研究[J].中华肝脏病杂志,2005,13(2):152-153. 被引量:5
  • 9Matrella E,Valatas V,Notas G,et al.Bolus somatostatin but not octreotide reduces hepatic sinusoidal pressure by a NO-independent mechanism in chronic liver disease[J].Aliment Pharmacol Therapeut,2001,15:857-864.

二级参考文献24

  • 1丁惠国,于中麟,李春林,王淑燕,董忠田.奥曲肽对实验性肝硬化血液动力学的影响及其作用机制探讨[J].中华消化杂志,1995,15(5):308-309. 被引量:17
  • 2Geerts A, Niki T, Hellemans K, et al. Purification of rat hepatic stellate cells by side scatter-activated cell sorting. Hepatology,1998, 27: 590-598.
  • 3Reynaert H, Vaeyens F, Qin H, et al. Somatostatin suppresses Endothelinl-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1. Gastroenterology, 2001, 121: 915-930.
  • 4Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol, 2000, 35: 665-672.
  • 5Pawlikowski M, Melen Mucha G. Perspectives of new potential therapeutic applications of somatostatin analogs. Neuroendocrinol Lett, 2003, 24: 21-27.
  • 6Karalis K, Mastorakos G, Chrousos GP, et al. Somatostatin analogues suppress the inflammatory reaction in vivo. J Clin Invest,1994, 93: 2000-2006.
  • 7Fort J, Oberti F, Pilette C, et al. Antifibrotic and hemodynamic effects of the early and chronic administration of octreotide in two models of liver fibrosis in rats. Hepatology, 1998, 28: 1525-1531.
  • 8Laznicek M, Laznickova A, Trejtnar F, et al. Lanreotide labeled with 99mTc: preparation, preclinical testing and comparison with (111)In-DTPA-octreotide. Anticancer Res, 2002, 22: 2125-2130.
  • 9Ferguson SS. Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev, 2001, 53: 1-24.
  • 10Li D, Friedman SL. Liver fibrogenesis and the role of hepatic stellate cells: new insight and prospects for therapy. J Gastroenterol Hepatol,1999, 14: 618-633.

共引文献12

同被引文献46

引证文献6

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部